Fresh Recalls

FDAClass III · Drug · Recall D-0585-2026 · Recalled June 17, 2026

Primidone Tablets recall — Amneal Pharmaceuticals, LLC

Agency report date: June 17, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Primidone Tablets
Company / brand
Amneal Pharmaceuticals
Lot / serial / date codes
Lot AM251676, EXP 11/31/2028
Distribution
Nationwide within the USA.
Agency product description and boundaries

Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC: 53746-544-01

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class III: not likely to cause adverse health consequences.

Affected product: Primidone Tablets

3. Open the official notice or contact

Official recall ID
D-0585-2026
Brand
Amneal Pharmaceuticals
Classification
Class III
Units affected
27,936 100-count bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Bridgewater, NJ, United States
Firm address
400 Crossing Blvd Fl 3, N/A, 08807-2863

Identifying details (verbatim from the notice)

Product codes / lots
Lot AM251676, EXP 11/31/2028
Distribution
Nationwide within the USA.
Firm notified the public via
Letter
FDA event ID
99146
Recall initiated
June 3, 2026
FDA classified
June 10, 2026
FDA report date
June 17, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page